维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

6篇 您的检索式：作者名="Unterhah"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	NPM1 but not FL33 - ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK - AML) or high - risk myelodysplastic syndrome (MDS) 显示文摘	Schneider F Hoster E Unterhah M	2009	Blood2009，113，：	1
	2	Fludarabine single-agent phase Ⅱ study of the German low-grade non-Hodgkin's lymphoma study group显示文摘	Hiddeman W Unterhah M Pott C	1993	Sem in Oncol1993，20，53：	1
	3	Maintenance therapy with Rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone(R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas : Results of a prospective randomized study of the German Low Grade Lymphoma Study Group(GLSG) 显示文摘	Forstpointner R Unterhah M Dreyling M	2006	Blood2006，108，：	1
	4	Effect of prolonged uremia on insulin metabolism by isolated liver and muscle 显示文摘	Rabkin R Unterhaher SA Duckworth WC	1979	Kidney Int1979，16，4：	1
	5	Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphoma:A phase Ⅱstudy of the German low-grade non-Hodgkin's lymphoma study grope显示文摘	Hiddeman W Unterhah M Pott C		0，，5：	1
	6	The addition of rituximab to first - line chemotherapy( R - CHOP)results in superior response rates, time to treatment failure and re- sponse duration in patients with advanced stage mantle cell lymphoma:long term results of a randomized GLSG trial 显示文摘	Hoster E Unterhah M Wormmann B	2008	Blood2008，112，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费